Table 2.
Clinical characteristics of the subjects
| Variables | Study 1 (n = 19) | Study 2 (n = 18) |
|---|---|---|
| Age, year | 53 ± 19 | 56 ± 15 |
| Sex, men/women | 14/5 | 12/6 |
| Body mass index, kg/m2 | 24.5 ± 4.1 | 23.2 ± 3.1 |
| Systolic blood pressure, mmHg | 130 ± 11 | 128 ± 13 |
| Diastolic blood pressure, mmHg | 77 ± 9 | 81 ± 8 |
| Heart rate, bpm | 65 ± 8 | 63 ± 9 |
| HbA1c, % | 5.4 ± 0.3 | 5.5 ± 0.4 |
| Medical history, n (%) | ||
| Borderline hypertension | 6 (31.6) | 3 (16.7) |
| Stage 1 hypertension | 13 (68.4) | 15 (83.3) |
| Dyslipidemia | 9 (47.4) | 7 (38.9) |
| Diabetes mellitus | 0 (0) | 0 (0) |
| Previous coronary heart disease | 0 (0) | 0 (0) |
| Previous stroke | 0 (0) | 0 (0) |
| Current smoker | 0 (0) | 0 (0) |
| Medications, n (%) | ||
| Calcium-channel blockers | 7 (36.7) | 9 (50.0) |
| Renin angiotensin system inhibitors | 0 (0) | 0 (0) |
| Statins | 0 (0) | 0 (0) |
| Medically treated diabetes | ||
| Any | 0 (0) | 0 (0) |
| Insulin-dependent | 0 (0) | 0 (0) |
Results are presented as mean ± SD or number (%)